CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,373,433 | -10.8% | 7,046,487 | +2.5% | 0.00% | 0.0% |
| Q2 2023 | $92,356,293 | -19.6% | 6,871,748 | -0.8% | 0.00% | -33.3% |
| Q1 2023 | $114,840,474 | -8.8% | 6,926,446 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $125,898,583 | +59.8% | 6,768,741 | +10.2% | 0.00% | +50.0% |
| Q3 2022 | $78,772,000 | +131.1% | 6,139,650 | +26.3% | 0.00% | +100.0% |
| Q2 2022 | $34,084,000 | -13.1% | 4,861,988 | +2.7% | 0.00% | 0.0% |
| Q1 2022 | $39,242,000 | +19.9% | 4,733,604 | -2.1% | 0.00% | 0.0% |
| Q4 2021 | $32,741,000 | +26.2% | 4,836,313 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $25,948,000 | -9.5% | 4,895,853 | -1.8% | 0.00% | 0.0% |
| Q2 2021 | $28,671,000 | +11.3% | 4,986,222 | -10.7% | 0.00% | 0.0% |
| Q1 2021 | $25,753,000 | +33.6% | 5,586,295 | -3.2% | 0.00% | 0.0% |
| Q4 2020 | $19,275,000 | +31.2% | 5,771,079 | +16.6% | 0.00% | – |
| Q3 2020 | $14,696,000 | -37.5% | 4,948,156 | -2.8% | 0.00% | -100.0% |
| Q2 2020 | $23,517,000 | +18.7% | 5,090,360 | -1.0% | 0.00% | 0.0% |
| Q1 2020 | $19,805,000 | +9.9% | 5,144,116 | +7.0% | 0.00% | 0.0% |
| Q4 2019 | $18,024,000 | -30.4% | 4,806,414 | -1.5% | 0.00% | 0.0% |
| Q3 2019 | $25,909,000 | +38.8% | 4,879,348 | +0.4% | 0.00% | 0.0% |
| Q2 2019 | $18,669,000 | -23.2% | 4,861,728 | +2.0% | 0.00% | 0.0% |
| Q1 2019 | $24,305,000 | +162.1% | 4,765,795 | -1.3% | 0.00% | – |
| Q4 2018 | $9,272,000 | -45.0% | 4,829,572 | +8.3% | 0.00% | -100.0% |
| Q3 2018 | $16,852,000 | +26.4% | 4,458,151 | +4.3% | 0.00% | 0.0% |
| Q2 2018 | $13,333,000 | +40.2% | 4,273,134 | +7.4% | 0.00% | – |
| Q1 2018 | $9,507,000 | -33.2% | 3,977,907 | +9.2% | 0.00% | -100.0% |
| Q4 2017 | $14,238,000 | +85.9% | 3,641,295 | +19.8% | 0.00% | – |
| Q3 2017 | $7,657,000 | -17.1% | 3,038,423 | -9.3% | 0.00% | – |
| Q2 2017 | $9,242,000 | +57.6% | 3,348,549 | +11.3% | 0.00% | – |
| Q1 2017 | $5,865,000 | +86.7% | 3,007,935 | +0.5% | 0.00% | – |
| Q4 2016 | $3,142,000 | -0.9% | 2,992,335 | +2.8% | 0.00% | – |
| Q3 2016 | $3,172,000 | +53.5% | 2,909,584 | 0.0% | 0.00% | – |
| Q2 2016 | $2,066,000 | -43.5% | 2,909,584 | -6.9% | 0.00% | – |
| Q1 2016 | $3,656,000 | -42.5% | 3,124,440 | +20.3% | 0.00% | – |
| Q4 2015 | $6,362,000 | -96.5% | 2,596,829 | -72.9% | 0.00% | -100.0% |
| Q3 2015 | $182,219,000 | +1740.6% | 9,567,912 | +299.1% | 0.01% | +600.0% |
| Q2 2015 | $9,900,000 | +2.6% | 2,397,138 | +7.6% | 0.00% | 0.0% |
| Q1 2015 | $9,650,000 | +66.8% | 2,228,589 | +14.4% | 0.00% | – |
| Q4 2014 | $5,785,000 | -7.1% | 1,947,849 | +3.9% | 0.00% | – |
| Q3 2014 | $6,227,000 | +37.6% | 1,875,449 | +4.9% | 0.00% | – |
| Q2 2014 | $4,525,000 | +22.5% | 1,788,642 | +9.4% | 0.00% | – |
| Q1 2014 | $3,695,000 | +32.1% | 1,634,860 | +14.0% | 0.00% | – |
| Q4 2013 | $2,797,000 | -23.2% | 1,434,118 | +20.1% | 0.00% | – |
| Q3 2013 | $3,643,000 | +637.4% | 1,194,318 | +115.0% | 0.00% | – |
| Q2 2013 | $494,000 | – | 555,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |